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In the previous issue of Critical Care, Vaschetto and 
colleagues [1] sought to determine whether and by which 
mechanism(s) the activation of poly(ADP-ribose) poly-
merase (PARP) contributes to the acute kidney injury 
(AKI) induced by injurious mechanical ventilation (MV). 
Th  e authors used a double-hit rat model of acute lung 
injury comprising lipopolysaccharide-induced lung inﬂ  am-
mation and MV with either very high tidal volume (19 mL/
kg, zero positive end-expiratory pressure [PEEP]) or low 
tidal volume (6 mL/kg, PEEP 5 cm H2O). To address the 
role of peroxynitrite and PARP in mediating MV-induced 
kidney injury, the rats challenged with high-tidal-volume 
MV were pre-treated with peroxynitrite decomposition 
catalyst (WW85) or a PARP inhibitor (PJ-34). Th  e  authors’ 
key ﬁ   ndings were that both strategies preserved renal 
perfusion, attenuated renal endothelial dysfunction, and 
ameliorated intrarenal inﬂ  ammation.
Th   e issue of AKI due to MV is an old but still virtually 
not understood phenomenon and is, however, of major 
concern [2]. Traditionally, deteriorations in systemic and 
renal hemodynamics and gas exchange associated with 
MV have been implicated in this process [3]. Th   ere is an 
emerging concept that MV exerts a broad spectrum of 
harmful biological responses with the capacity to aﬀ  ect 
functions of remote organs [4,5], including the kidney 
[6,7]. An altered inﬂ  ammatory net  work, oxidative stress, 
and apoptosis have been con  sidered the central hubs of 
this organ crosstalk in response to MV [8,9].
Generation of reactive oxygen and nitrogen species has 
been demonstrated during various acute conditions [10]. 
One of the most important secondary injuries resulting 
from oxidative stress is oxidative DNA damage leading to 
overactivation of PARP. Its activation results in depletion of 
NAD+ and ATP and consequently in cell death and organ 
dysfunction [10]. Not only compromised cellular energy 
metabolism but also PARP-mediated upregulation of 
numerous pro-inﬂ  ammatory pathways makes the pharma-
cological modulation of PARP activity a suitable target to 
prevent the tissue injury [10-12]. Th   erefore, the hypothesis 
of the peroxynitrite-PARP-dependent path  way as an 
important pathogenic contributor to ventilator-induced 
kidney injury [8] is tempting. Indeed, evidence derived 
from several studies suggests that PARP is activated in 
both ventilator-induced lung injury (VILI) [13] and AKI 
[14]. In addition to direct PARP inhibition, neutralization 
of cytotoxic eﬀ  ects of molecules such as iNOS (inducible 
nitric-oxide synthase)-derived nitric oxide might constitute 
an interesting tool to protect the kidney [15,16].
Th  e study by Vaschetto and colleagues [1] is a 
complementary experimental study of the research group 
that has previously demonstrated impressive beneﬁ  cial 
eﬀ   ects of PARP inhibition on VILI, systemic inﬂ  am-
matory response, and kidney function in a very similar 
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Both acute lung injury and acute kidney injury (AKI) 
are frequent and serious problems in intensive care 
medicine. Therefore, the avoiding of any iatrogenic 
insult to these organs is of great importance. While an 
increasing body of evidence suggests that mechanical 
ventilation is capable of inducing lung and distant 
organ injury, the complex underlying molecular 
mechanisms remain insuffi   ciently understood. In the 
previous issue of Critical Care, Vaschetto and colleagues 
reported the results of an experimental study designed 
to further explore pathways linking injurious ventilation 
with AKI. The authors demonstrated that scavenging of 
peroxynitrite or inhibiting poly(ADP-ribose) polymerase 
(PARP) aff  orded protection against AKI induced by 
double-hit lung injury. Although PARP inhibition or 
peroxynitrite detoxifi  cation or both may become viable 
candidates for a protective strategy in this setting, 
the implementation of a lung-protective ventilatory 
strategy remains the only clinical tool to mitigate the 
lung biotrauma and its systemic consequences.
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these ﬁ   ndings by providing further insights into the 
mecha  nisms by which PARP inhibition provides kidney 
protection. Peroxinitrite-PARS (poly[ADP-ribose] synthe-
tase) inhibition preserved renal microvascular stability 
and attenuated renal tissue leukocyte inﬁ  ltration. Th  ese 
ﬁ   ndings are of particular relevance to the kidney as 
recent research underscored the importance of renal 
microcirculation and intrarenal inﬂ  ammation as possibly 
causative features in AKI [18,19].
Although we have learned a great deal from the study 
by Vaschetto and colleagues [1], some critical aspects of 
the study need to be addressed. To induce signiﬁ  cant 
VILI and remote organ dysfunction, the authors had to 
use highly injurious ventilatory settings associated with 
profound hypotension and this use would be considered 
non lege artis in clinical practice. Moreover, no standard 
therapeutic measures such as ﬂ   uid resuscitation or 
vasoactive drugs to maintain renal blood ﬂ  ow  were 
administered. Finally, they tested the role of the 
peroxynitrite-PARP-dependent pathway in animals 
challenged with high tidal volume only, thus leaving its 
role in clinically more relevant scenarios open to 
speculation. In fact, in their previous study, the authors 
observed no signiﬁ  cant  diﬀ   erences between animals 
venti  lated with low tidal volume (6  mL/kg, PEEP 
5 cm H2O) and treated or not treated with PARP inhibi-
tion [17]. Th   erefore, it is tempting to speculate that lung-
protective ventilation might produce only subtle inﬂ  am-
matory insults insuﬃ   cient to trigger PARP overactivation 
in remote organs. Furthermore, the short-term nature 
and pre-treatment design of the study as well as the lack 
of direct measurements of time-related changes in tissue 
PARP activity and 3-nitrotyrosine (an index of peroxy-
nitrite) make the applicability of the results to the clinical 
scenario problematic. Finally, the double-hit model does 
not allow investigators to dissect whether the major 
stimulus for peroxynitrite-PARP-derived toxicity is endo-
toxin or injurious ventilation or both.
Where do we go from here? Mitigation of VILI-induced 
lung and remote organ injury by interfering with the 
pathobiological pathways involved is a promising 
concept, albeit still far from the clinical arena. Th  ough 
leaving important aspects open to speculation, the 
studies by Vaschetto and colleagues provide interesting 
mechanistic insights into the increasingly challenging 
aspects of the complex inﬂ  ammatory network implicated 
in bidirectional organ crosstalk and should stimulate 
further research in this direction.
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